在使用库马尔宫颈施源器进行9000拉德腔内近距离放射治疗（ECT）及外照射放疗（EXRT）治疗子宫颈癌时，发病率较低。
Low morbidity following 9,000-rad intracavitary endocurietherapy (ECT) using the Kumar Cervical Applicator and external-beam radiotherapy (EXRT) in the management of carcinoma of the uterine cervix.
作者信息
Kumar P P, Good R R, Scott J C, Jones E O, Lynch G, McCaul G F
机构信息
Faculty of the Division of Radiation Oncology, University of Nebraska College of Medicine, Omaha.
出版信息
Radiat Med. 1988 Mar-Apr;6(2):92-106.
The Kumar Cervical Applicator minimizes patient discomfort and improves patient mobility while reducing the tendency of the applicator to rotate during the 40 to 50 hours of uterine intracavitary endocurietherapy. Patients with previously untreated invasive carcinoma of the uterine cervix, F.I.G.O. stages IB-IVA, were treated with two Kumar intracavitary endocurietherapy (ECT) applications of 2,500 rad each to point "A," and 4,000 rad external-beam radiotherapy (EXRT) to midplane, for a total dose of 9,000 rad. The major complication rate was 2.7%, and the local control rate was 85% (22/26 patients) for stage I and II, and 91% (10/11 patients) for stage III and IVA.
库马尔宫颈施源器可最大程度减轻患者不适并提高患者活动能力，同时在子宫腔内近距离放射治疗的40至50小时内降低施源器旋转的倾向。对国际妇产科联盟（F.I.G.O.）分期为IB-IVA期的既往未经治疗的子宫颈浸润癌患者，采用库马尔腔内近距离放射治疗（ECT），每次向“A”点施加2500拉德，共两次，同时对中平面进行4000拉德的外照射放疗（EXRT），总剂量为9000拉德。I期和II期患者的主要并发症发生率为2.7%，局部控制率为85%（26例患者中的22例），III期和IVA期患者的局部控制率为91%（11例患者中的10例）。
Zotero 插件